Neuroleptic Malignant Syndrome: Clinical Trials

2 trials for Neuroleptic Malignant Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 11Recruiting 1

Follow Neuroleptic Malignant Syndrome: new trials by email Literature Review of Neuroleptic Malignant Syndrome trials Research Report on Neuroleptic Malignant Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Atamparib in Patients With Advanced Solid Tumors
atamparib escalation levels, atamparib RP2D - NSCLC Adenocarcinoma, Solid Tumor
Phase 1 / Phase 2RecruitingNerviano Medical Sciences (Shanghai) Ltd.1782026-03-182026-07-29
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia
t-VNS verum, t-VNS placebo - Schizophrenia
Phase 2Completedcerbomed GmbH202010-03-012012-09-12

Narrower conditions

Delusions (1)  ·  Dementia (1)  ·  Hallucinations (1)  ·  Illusions (1)  ·  Mental Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Schizophrenia, Catatonic (1)  ·  Schizophrenia, Disorganized (1)  ·  Schizophrenia, Paranoid (1)  ·  Tardive Dyskinesia (1)

Broader conditions

Basal Ganglia Diseases (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Chemically-Induced Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurotoxicity Syndromes (2)  ·  Poisoning (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Dyskinesia, Drug-Induced (1)  ·  Dyskinesias (1)  ·  Movement Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)

Sponsors

Nerviano Medical Sciences (Shanghai) Ltd. (1)  ·  cerbomed GmbH (1)

Countries

China (1)  ·  Germany (1)

Top investigators

Caicun Zhou, Dr. (1)